Amarin Corp Plc (AMRN)

[mrmainstreet]

Why is it so hard to understand that those of us buying under $2 think the stock will provide a solid ROI from here? The company has a safe, approved, affordable drug with good margins.

They have stabilized the US scripts IMO with these exclusivity deals, and are getting EU/ROW built up. Denner is on board as a 6% shareholder and his track record is interesting as an activist investor.

I know you're working the board hard to talk your book, but surely it can't be that surprising that buyers think there is value at these levels.